A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study)

A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study) / Manzia, Tommaso Maria; Carmellini, Mario; Todeschini, Paola; Secchi, Antonio; Sandrini, Silvio; Minetti, Enrico; Furian, Lucrezia; Spagnoletti, Gionata; Pisani, Francesco; Piredda, Gian Benedetto; Cappelli, Gianni; Tisone, Giuseppe. - In: TRANSPLANTATION. - ISSN 0041-1337. - 104:2(2020), pp. 374-386. [10.1097/TP.0000000000002851]